18/06/2013
Horizon Discovery and Hisun Pharmaceuticals Partner on Gene-Engineered Bioproduction Cell Line
Precisely engineered CHO cell line will enable faster, more efficient development... (more)

03/06/2013
Horizon Discovery Announces £6.9 Million ($10.5 Million) Series C Continuation Fundraising
Horizon Discovery Announces £6.9 Million ($10.5 Million) Series C Continuation... (more)

22/04/2013
Horizon Discovery Announces Oncology Drug Discovery Collaboration with AstraZeneca
Cambridge, UK, 22 April 2013: Horizon Discovery (Horizon) and AstraZeneca have entered... (more)

15/04/2013
Horizon Discovery and Diatech Pharmacogenetics Sign Distribution Agreement
Agreement covers distribution of Horizon Diagnostics’ molecular reference standards... (more)

03/04/2013
Crown Bioscience, Inc. and Horizon Discovery Announce Exclusive Two Year Agreement to Offer Combined Solutions for In Vivo Drug Discovery Model Development
Santa Clara, CA and Cambridge, UK (April 3rd 2013) – Crown Bioscience, Inc.... (more)

05/03/2013
Horizon Introduces Quantitative Multiplex Genomic Reference Standards for Tumor Profiling
Increasing the precision and utility of molecular assays for cancer genotype screening Cambridge,... (more)

04/03/2013
Horizon Discovery Establishes Three New Centers of Excellence in Asia
Centers will apply Horizon’s rAAV gene editing technology to a range of oncology... (more)

11/02/2013
Horizon Discovery Wins Most Promising Company at World Conference on Personalized Medicine
Award based on technology, performance to date, and forward plans Cambridge and... (more)

14/01/2013
Horizon Discovery and Boehringer Ingelheim Enter Oncology Research Service Collaboration
Five-year collaboration will support Boehringer Ingelheim’s drug discovery... (more)